These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19621069)

  • 1. Can the relationship between doctors and drug companies ever be a healthy one?
    D'Arcy E; Moynihan R
    PLoS Med; 2009 Jul; 6(7):e1000075. PubMed ID: 19621069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doctors and drug companies.
    Blumenthal D
    N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823
    [No Abstract]   [Full Text] [Related]  

  • 3. Doctors and drug companies: the beauty and the beast?
    Guömundsson S
    Acta Ophthalmol Scand; 2005 Aug; 83(4):407-8. PubMed ID: 16029261
    [No Abstract]   [Full Text] [Related]  

  • 4. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doctors, drug companies and medical ethics: a Sri Lankan perspective.
    Malavige GN
    Indian J Med Ethics; 2004; 1(1):26. PubMed ID: 16370067
    [No Abstract]   [Full Text] [Related]  

  • 6. Money for drugs: should physicians be paid for pharmaceutical development and clinical investigations?
    Van Way C; Bohigian G; Gale A; Powell M; Hagan JC
    Mo Med; 2011; 108(5):320-9. PubMed ID: 22073488
    [No Abstract]   [Full Text] [Related]  

  • 7. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement.
    Moynihan R
    BMJ; 2003 May; 326(7400):1189-92. PubMed ID: 12775621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doctors and drug companies--scrutinizing influential relationships.
    Campbell EG
    N Engl J Med; 2007 Nov; 357(18):1796-7. PubMed ID: 17978288
    [No Abstract]   [Full Text] [Related]  

  • 9. Doctors and drug companies.
    Lambert LA
    N Engl J Med; 2005 Feb; 352(7):733-4; author reply 733-4. PubMed ID: 15716575
    [No Abstract]   [Full Text] [Related]  

  • 10. [There is no Season for Gifts].
    Lieb K; Koch C
    Dtsch Med Wochenschr; 2017 Dec; 142(25):1949-1953. PubMed ID: 29241283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ethics of pharmaceutical industry relationships with medical students.
    Rogers WA; Mansfield PR; Braunack-Mayer AJ; Jureidini JN
    Med J Aust; 2004 Apr; 180(8):411-4. PubMed ID: 15089733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No more free lunches: doctors and journals in the South cut off drug companies at their peril.
    Ana J
    BMJ; 2003 Aug; 327(7410):341-2. PubMed ID: 12907496
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is it pertinent to investigate the relations between physicians and the drug industry].
    Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
    Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry.
    Barnes RK
    Med J Aust; 2010 Mar; 192(5):294-5. PubMed ID: 20306549
    [No Abstract]   [Full Text] [Related]  

  • 15. Dangerous liaisons: doctors-in-training and the pharmaceutical industry.
    Pokorny AM; Gittins CB
    Intern Med J; 2015 Oct; 45(10):1085-8. PubMed ID: 26429220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry.
    Gough IR; Dickinson I; Maddern G; Grigg M; Hillis DJ
    Med J Aust; 2010 Mar; 192(5):293-4. PubMed ID: 20201768
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ethics and Transparency Committee on the Relationship Physician-Industry (CETREMI); suggestions to doctors in their relations with pharmaceutical industry].
    Lifshitz A; Halabe J; Jasso L; Frati A; Alva C; Arrieta Ó; Burgos R; Campillo C; Celis MÁ; de la Llata M; Domínguez J; Islas R; Moreno M; Plancarte R; Reyes A; Soda A; Verástegui E; Sotelo J
    Gac Med Mex; 2016; 152(3):295-6. PubMed ID: 27335182
    [No Abstract]   [Full Text] [Related]  

  • 18. How to dance with porcupines: rules and guidelines on doctors' relations with drug companies.
    Wager E
    BMJ; 2003 May; 326(7400):1196-8. PubMed ID: 12775623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Money for drugs: should physicians be paid for pharmaceutical development and clinical investigations?
    Van Way CW; Bohigian G
    Mo Med; 2011; 108(6):414. PubMed ID: 22338732
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical students protest perks from drug companies.
    Opar A
    Nat Med; 2006 Oct; 12(10):1104. PubMed ID: 17024192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.